• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.碳青霉烯类药物帕尼培南的活性以及OprD(D2)蛋白在其通过铜绿假单胞菌外膜扩散中的作用。
Antimicrob Agents Chemother. 1993 Feb;37(2):322-7. doi: 10.1128/AAC.37.2.322.
2
Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates.碱性氨基酸对临床分离的铜绿假单胞菌对碳青霉烯类药物敏感性的影响。
Int J Med Microbiol. 2003 Jun;293(2-3):191-7. doi: 10.1078/1438-4221-00256.
3
Meropenem permeation through the outer membrane of Pseudomonas aeruginosa can involve pathways other than the OprD porin channel.美罗培南透过铜绿假单胞菌外膜的过程可能涉及除OprD孔蛋白通道之外的其他途径。
Chemotherapy. 1996 May-Jun;42(3):210-14. doi: 10.1159/000239444.
4
In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.BO-2727 对亚胺培南和/或美罗培南耐药铜绿假单胞菌的体外和体内评价
J Antibiot (Tokyo). 1997 Feb;50(2):135-8. doi: 10.7164/antibiotics.50.135.
5
Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.韩国医院分离出的耐碳青霉烯类铜绿假单胞菌中OprD的突变失活
J Microbiol. 2016 Jan;54(1):44-49. doi: 10.1007/s12275-016-5562-5. Epub 2016 Jan 5.
6
Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.铜绿假单胞菌对碳青霉烯类抗生素的耐药机制:孔蛋白OprD和外排蛋白的改变不能完全解释临床分离株中观察到的耐药模式。
APMIS. 2005 Mar;113(3):187-96. doi: 10.1111/j.1600-0463.2005.apm1130306.x.
7
Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates.检测铜绿假单胞菌临床分离株中外膜孔蛋白(一种亚胺培南流入通道)。
Southeast Asian J Trop Med Public Health. 2010 May;41(3):614-24.
8
C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem.铜绿假单胞菌外膜孔蛋白OprD的C末端区域调节对美罗培南的敏感性。
Antimicrob Agents Chemother. 2001 Jun;45(6):1780-7. doi: 10.1128/AAC.45.6.1780-1787.2001.
9
OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.韩国碳青霉烯类耐药铜绿假单胞菌分离株中 oprD 突变和失活、外排泵表达和 AmpC 以及金属β-内酰胺酶。
Int J Antimicrob Agents. 2012 Aug;40(2):168-72. doi: 10.1016/j.ijantimicag.2012.04.004. Epub 2012 May 26.
10
Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa.铜绿假单胞菌外膜孔蛋白OprD底物选择性的遗传学定义
J Bacteriol. 1993 Dec;175(24):7793-800. doi: 10.1128/jb.175.24.7793-7800.1993.

引用本文的文献

1
Genomic Analysis of Antimicrobial Resistance in from a "One Health" Perspective.从“同一个健康”视角对抗菌药物耐药性进行基因组分析。 (你提供的原文有缺失部分,推测可能是某种生物从“同一个健康”视角对抗菌药物耐药性进行基因组分析,我按完整意思进行了翻译补充,若与你原意不符,请你指出。)
Microorganisms. 2024 Aug 27;12(9):1770. doi: 10.3390/microorganisms12091770.
2
Location, Location, Location: Establishing Design Principles for New Antibacterials from Ferric Siderophore Transport Systems.位置,位置,位置:从铁载体转运系统中建立新型抗菌药物的设计原则。
Molecules. 2024 Aug 16;29(16):3889. doi: 10.3390/molecules29163889.
3
Activity of zinc oxide and zinc borate nanoparticles against resistant bacteria in an experimental lung cancer model.氧化锌和硼酸锌纳米粒子对实验性肺癌模型中耐药菌的活性。
Daru. 2024 Jun;32(1):197-206. doi: 10.1007/s40199-024-00505-2. Epub 2024 Feb 17.
4
Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.针对病原菌群体感应、生物膜形成和抗生素耐药性的“神圣三角”
Microorganisms. 2022 Jun 16;10(6):1239. doi: 10.3390/microorganisms10061239.
5
Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.ESKAPE病原体对抗生素的逃逸机制及其被天然化合物的靶向作用
Biotechnol Rep (Amst). 2022 Apr 4;34:e00728. doi: 10.1016/j.btre.2022.e00728. eCollection 2022 Jun.
6
Targeted Genome Reduction of Strain PAO1 Led to the Development of Hypovirulent and Hypersusceptible rDNA Hosts.对PAO1菌株进行靶向基因组缩减导致了低毒力和高敏感性核糖体DNA宿主的产生。
Front Bioeng Biotechnol. 2021 Mar 11;9:640450. doi: 10.3389/fbioe.2021.640450. eCollection 2021.
7
Antibiotic resistance and persistence-Implications for human health and treatment perspectives.抗生素耐药性和持久性-对人类健康的影响和治疗观点。
EMBO Rep. 2020 Dec 3;21(12):e51034. doi: 10.15252/embr.202051034. Epub 2020 Dec 8.
8
Host Environment Alters Susceptibility to Aminoglycoside Antibiotics.宿主环境改变对氨基糖苷类抗生素的易感性。
Front Cell Infect Microbiol. 2017 Mar 14;7:83. doi: 10.3389/fcimb.2017.00083. eCollection 2017.
9
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.ESKAPE 病原体中的抗菌耐药机制。
Biomed Res Int. 2016;2016:2475067. doi: 10.1155/2016/2475067. Epub 2016 May 5.
10
Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.表型异质性使尿路致病性大肠杆菌能够逃避抗生素和血清补体的杀伤作用。
Infect Immun. 2015 Mar;83(3):1056-67. doi: 10.1128/IAI.02725-14. Epub 2015 Jan 5.

本文引用的文献

1
Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.N-甲酰亚胺硫霉素对革兰氏阳性和革兰氏阴性需氧及厌氧菌的体外比较活性及其β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1982 Jan;21(1):180-7. doi: 10.1128/AAC.21.1.180.
2
MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.MK0787(N-亚胺甲酰硫霉素):体内外活性评估
Antimicrob Agents Chemother. 1980 Jun;17(6):993-1000. doi: 10.1128/AAC.17.6.993.
3
Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes.铜绿假单胞菌外膜对亲水性溶质的通透性。
J Bacteriol. 1982 Nov;152(2):636-42. doi: 10.1128/jb.152.2.636-642.1982.
4
A simple method for the study in vivo of bacterial growth and accompanying host response.一种用于体内研究细菌生长及伴随的宿主反应的简单方法。
J Infect. 1980 Mar;2(1):39-51. doi: 10.1016/s0163-4453(80)91773-9.
5
In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.亚胺培南对临床分离细菌的体外及体内抗菌活性
J Antimicrob Chemother. 1983 Dec;12 Suppl D:53-64. doi: 10.1093/jac/12.suppl_d.53.
6
Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.亚胺培南治疗铜绿假单胞菌及其他严重细菌感染。
Antimicrob Agents Chemother. 1984 Nov;26(5):673-7. doi: 10.1128/AAC.26.5.673.
7
Postantibiotic effect of imipenem on Pseudomonas aeruginosa.亚胺培南对铜绿假单胞菌的抗生素后效应。
Antimicrob Agents Chemother. 1984 Nov;26(5):678-82. doi: 10.1128/AAC.26.5.678.
8
Thienamycin: development of imipenen-cilastatin.硫霉素:亚胺培南-西司他丁的研发
J Antimicrob Chemother. 1983 Dec;12 Suppl D:1-35. doi: 10.1093/jac/12.suppl_d.1.
9
Porin channels in Escherichia coli: studies with beta-lactams in intact cells.大肠杆菌中的孔蛋白通道:在完整细胞中使用β-内酰胺类药物的研究
J Bacteriol. 1983 Jan;153(1):232-40. doi: 10.1128/jb.153.1.232-240.1983.
10
Ion-exchange chromatography of amino acids in sweat collected from healthy subjects during sauna bathing.对健康受试者在桑拿浴期间收集的汗液中的氨基酸进行离子交换色谱分析。
Clin Chem. 1974 Oct;20(10):1305-12.

碳青霉烯类药物帕尼培南的活性以及OprD(D2)蛋白在其通过铜绿假单胞菌外膜扩散中的作用。

Activity of the carbapenem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane.

作者信息

Fukuoka T, Ohya S, Narita T, Katsuta M, Iijima M, Masuda N, Yasuda H, Trias J, Nikaido H

机构信息

Biological Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

出版信息

Antimicrob Agents Chemother. 1993 Feb;37(2):322-7. doi: 10.1128/AAC.37.2.322.

DOI:10.1128/AAC.37.2.322
PMID:8452364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC187661/
Abstract

Evidence of permeation of panipenem through the OprD (D2) channel of Pseudomonas aeruginosa outer membrane was shown by using OprD protein-producing and -nonproducing strains which contained plasmid pHN4, which codes for L-1 beta-lactamase of Xanthomonas maltophilia. Permeation by panipenem was determined by measuring hydrolysis of the carbapenem by beta-lactamase in the periplasmic space. Permeation by panipenem was also determined by counting uptake of [14C]panipenem into P. aeruginosa PAO1 and its OprD protein-deficient mutant, and this permeation of PAO1 was inhibited by L-lysine. These results indicate that panipenem, as well as imipenem, uses the OprD channel, which functions as a specific channel for diffusion of basic amino acids. Panipenem and imipenem showed stronger activities against PAO1 and clinical isolates in human serum than in Mueller-Hinton broth, which contains more amino acids than human serum does. The activities of the carbapenems were reduced by addition of L-lysine to human serum. Similar results were obtained with mouse serum and ascitic fluid. In contrast, such a change in the activities of carbapenems was not observed with an OprD protein-deficient mutant, suggesting that the main reason for the strong activities of carbapenems in biological fluids is a decrease in competition between the antibiotics and basic amino acids for permeation through the OprD channel. Panipenem and imipenem showed much stronger therapeutic efficacies against experimental infections with P. aeruginosa in mice than did the reference antibiotics. Their in vivo activities were more consistent with their MICs in biological fluids than with those in Mueller-Hinton broth.

摘要

通过使用含有编码嗜麦芽窄食单胞菌L-1β-内酰胺酶的质粒pHN4的产OprD蛋白菌株和不产OprD蛋白菌株,证明了帕尼培南可透过铜绿假单胞菌外膜的OprD(D2)通道。通过测量周质空间中β-内酰胺酶对碳青霉烯的水解来确定帕尼培南的渗透情况。还通过计算[14C]帕尼培南进入铜绿假单胞菌PAO1及其OprD蛋白缺陷型突变体的摄取量来确定帕尼培南的渗透情况,并且PAO1的这种渗透被L-赖氨酸抑制。这些结果表明,帕尼培南与亚胺培南一样,利用OprD通道,该通道作为碱性氨基酸扩散的特异性通道。帕尼培南和亚胺培南在人血清中对PAO1和临床分离株的活性比对含有比人血清更多氨基酸的穆勒-欣顿肉汤中的活性更强。向人血清中添加L-赖氨酸会降低碳青霉烯类药物的活性。在小鼠血清和腹水中也获得了类似的结果。相比之下,在OprD蛋白缺陷型突变体中未观察到碳青霉烯类药物活性的这种变化,这表明碳青霉烯类药物在生物体液中活性强的主要原因是抗生素与碱性氨基酸在通过OprD通道渗透方面的竞争减少。帕尼培南和亚胺培南对小鼠铜绿假单胞菌实验性感染的治疗效果比参考抗生素强得多。它们的体内活性与其在生物体液中的最低抑菌浓度比与其在穆勒-欣顿肉汤中的最低抑菌浓度更一致。